factor gene TNF (rs1800629) in patients with hives and in the
control group of individuals. The material
Рахматуллин, А. Р.,
Бахтиярова, К.З.,
Магжанов Р.В.,
Rakhmatullin, A.R.,
Bakhtiyarova, K.Z.,
Magzhanov, R.V. (2017) .8±1.17 points. The
control group consisted of 24 healthy subjects matched by age and sex with the main group. A
Хасанова, Г.М.,
Тулян, А.В.,
Музыченко, А.В.,
Хасанова, А.Н.,
Khasanova, G.M.,
Tutelyan, A.V.,
Muzychenko, A.V.,
Khasanova, A.N. (2017) therapy received Imunofan and a vitamin-mineral complex). A healthy
control group comprised 44 practically
Мироненкова, Ж.В.,
Муссави, М.Э.,
Давлетьянова, А.Ф.,
Mironenkova, Zh.V.,
Moussawi, M.A.,
Davletianova, A.F. (2017) , statistical reporting materials of the
Center for AIDS Prevention and
Control of the Lebanese Republic
Zelinska, N.,
Iotova, V.,
Skorodok, J.,
Malievsky, O.,
Peterkova, V.,
Samsonova, L.,
Rosenfeld, Ron G.,
Zadik, Zvi,
Jaron-Mendelson, Michal,
Koren, Ronit,
Amitzi, Leanne,
Raduk, Dmitri,
Hershkovitz, Oren,
Hart, Gili (2017) : A multicenter, open-label, randomized,
controlled phase 2 study in children with GHD,
evaluating
Chatelain, Pierre,
Malievskiy, Oleg,
Radziuk, Klaudziya,
Senatorova, Ganna,
Abdou, Magdy O.,
Vlachopapadopoulou, Elpis,
Skorodok, Yulia,
Peterkova, Valentina,
Leff, Jonathan A.,
Beckert, Michael (2017) children with GHD.
Design: Randomized, open-label, active-
controlled study of three doses of weekly Trans